White coat hypertension in definition of metabolic syndrome

International Heart Journal

Volumn 49, Issue 4, 2008, Pages 449-457

  Helvaci, Mehmet Rami ^a   Kaya, Hasan ^a   Seyhanli, Mahmut ^b   Yalcin, Atilla ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

Dyslipidemia; Excess weight; Impaired glucose tolerance; Metabolic syndrome; White coat hypertension

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; WEIGHT GAIN; WHITE COAT HYPERTENSION; ADOLESCENT; AGED; BLOOD; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TURKEY (REPUBLIC);

LIPID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TURKEY;

EID: 52149103342     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.449     Document Type: Article

References (24)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
3. Tonkin AM. The metabolic syndrome(s)? Curr Atheroscler Rep 2004; 6: 165-6.
4. Franklin SS, Barboza MG, Pio JR, Wong ND. Blood pressure categories, hypertensive subtypes, and the metabolic syndrome. J Hypertens 2006; 24: 2009-16.
5. Clark LT, El-Atat F. Metabolic Syndrome in African Americans: implications for preventing coronary heart disease. Clin Cardiol 2007; 30: 161-4.
6. Ohkubo T, Asayama K, Kikuya M, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099- 104.
7. Nakashima T, Yamano S, Sasaki R, et al. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res 2004; 27: 739-45.
8. Curgunlu A, Karter Y, Uzun H, et al. Hyperhomocysteinemia: an additional risk factor in white coat hypertension. Int Heart J 2005; 46: 245-54.
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 17: 106: 3143-421.
10. O'Brien E, Asmar R, Beilin L, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-48.
11. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251-7.
12. Mulè G, Nardi E, Cottone S, et al. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. J Hum Hypertens 2007; 21: 854-60.
13. Helvaci MR, Seyhanli M. What a high prevalence of white coat hypertension in society! Intern Med 2006; 45: 671-4.
14. Hozawa A, Ohkubo T, Kikuya M, et al. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res 2002; 25: 57-63.
15. Celis H, Fagard RH. White-coat hypertension: a clinical review. Eur J Intern Med 2004; 15: 348-57.
16. Helvaci MR, Kaya H, Duru M, Yalcin A. What is the relationship between white coat hypertension and dyslipidemia? Int Heart J 2008; 49: 87-93.
17. Helvaci MR, Kaya H, Seyhanli M, Cosar E. White coat hypertension is associated with a greater all-cause mortality. J Health Sci 2007; 53: 156-60.
18. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation 2002; 106: 63-8.
19. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
20. Helvaci MR, Ozcura F, Kaya H, Yalcin A. Funduscopic examination has limited benefit for management of hypertension. Int Heart J 2007; 48: 187-94.
21. Helvaci MR, Kaya H, Yalcin A, Kuvandik G. Prevalence of white coat hypertension in underweight and overweight subjects. Int Heart J 2007; 48: 605-13.
22. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005; 28: 2823-31.
23. Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005; 2: 31.
24. Helvaci MR, Kaya H, Borazan A, Ozer C, Seyhanli M, Yalcin A. Metformin and parameters of physical health. Intern Med 2008; 47: 697-703.